DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
Lievre A, Bachet JB, Le CorreD. et al.
KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.
Cancer Res 2006;
66: 3992-3995
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.